retatrutide phase 2 nejm 2023 weight loss percent 48 weeks Dosage: Titration Schedule Does Retatrutide Make You Lose

This article will be updated when peer-reviewed publications become available.

GLP-1 is a natural peptide your body releases from the GI tract right after you eat

Some of the potential medicines coming down the pipeline include: Survodutide , mazdutide , and pemvidutide , weekly injectable drugs that work on both GLP-1 and glucagon receptors to help reduce weight and lower blood sugar Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon that comes in a once-weekly injection Pramlintide and cagrilintide, injectable drugs that work by acting on receptors for amylin, a hormone produced by the pancreas that plays a role in blood sugar control and satiety (fullness) How long will I take weight loss medications

All pharmacokinetic data cited here comes from the published Phase 2 trial

It works by activating three key pathways that control hunger, energy, and fat metabolism giving your body the boost it needs to transform from the inside out

Many titration schedules span approximately: 12 to 20 weeks for gradual progression longer timelines when slower adjustments are preferred Some individuals remain at moderate dose levels long term if desired outcomes are achieved